Novo Nordisk’s stock hits new record after initial data on oral weight-loss drug
Novo Nordisk’s stock hit a fresh record high as the Danish drugmaker held a capital-market day, presenting the next generation of drugs that have propelled it to becoming Europe’s largest company by market capitalization.